Clinical Evidence under EU MDR: Leveraging FDA Clinical Data to Streamline EU MDR Compliance
FDA approval alone is not sufficient for European market access - a theme we explore futher in this article and the accompanying webinar.
Thanks for your interest in our free CEP offer. Unfortunately, you don’t meet the eligibility criteria at this time.
However, we don’t want you to leave empty-handed — you can still access our CEP template, completely free, to help guide your compliance journey.
FDA approval alone is not sufficient for European market access - a theme we explore futher in this article and the accompanying webinar.
This guest article from our partner Cyber Alchemy shows you how to build cybersecurity evidence for the EU MDR and NHS DTAC.
Cyber Alchemy × Mantra Systems — Episode 1: All three markets operate under different regulatory systems and place different demands on manufacturers.
Implementation of the EU MDR 2017/745 has brought significant changes.
We're proud to join a this initiative supporting healthcare workers and patients to develop innovative solutions for the NHS.
We compare manufacturer-specific post-market obligations across both regulatory systems.